LHLABCORP HOLDINGS INC.

NYSE labcorp.com


$ 226.49 $ -0.12 (-0.05 %)    

Tuesday, 17-Sep-2024 09:57:12 EDT
QQQ $ 475.05 $ -0.92 (-0.19 %)
DIA $ 417.86 $ -0.13 (-0.03 %)
SPY $ 564.52 $ -0.61 (-0.11 %)
TLT $ 101.04 $ -0.35 (-0.34 %)
GLD $ 237.88 $ -0.10 (-0.04 %)
$ 225.76
$ 226.61
$ 226.17 x 103
-- x --
$ 226.11 - $ 227.82
$ 191.37 - $ 237.72
574,992
na
19.98B
$ 1.11
$ 44.45
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-26-2024 12-31-2023 10-K
4 10-30-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 10-30-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 05-01-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 04-28-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 05-04-2015 03-31-2015 10-Q
39 02-26-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cinven-to-sell-15-stake-in-synlab-to-labcorp-for-140m

Cinven has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and speci...

 reported-earlier-labcorp-prices-2b-in-senior-notes-offering-across-three-tranches-due-2030-2032-and-2034

LCAH expects to use the net proceeds of the Offering to redeem or repay indebtedness, which is expected to include $400.0 milli...

Core News & Articles

The acquisition includes BioReference Health's laboratory testing businesses focused on clinical diagnostics and reproducti...

 diagnostic-giants-labcorp-roche-to-ramp-up-testing-capacity-amid-global-concerns-over-new-mpox-strain

Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Qu...

 labcorp-working-with-cdc-to-monitor-mpox-outbreak-currently-processing-500-tests-monthly-has-capacity-for-25kmonth

-Reuters

 b-of-a-securities-maintains-buy-on-labcorp-holdings-raises-price-target-to-260

B of A Securities analyst Derik De Bruin maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $2...

 doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

 deutsche-bank-maintains-hold-on-labcorp-holdings-raises-price-target-to-230

Deutsche Bank analyst Pito Chickering maintains Labcorp Holdings (NYSE:LH) with a Hold and raises the price target from $220...

 ubs-maintains-buy-on-labcorp-holdings-raises-price-target-to-270

UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $260 to $270.

 barclays-maintains-equal-weight-on-labcorp-holdings-raises-price-target-to-249

Barclays analyst Stephanie Davis maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises the price target from $...

 baird-maintains-outperform-on-labcorp-holdings-raises-price-target-to-277

Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the price target from $261 to ...

 truist-securities-maintains-buy-on-labcorp-holdings-raises-price-target-to-275

Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $...

 labcorp-receives-fda-de-novo-marketing-authorization-for-pgdx-elio-plasma-focus-dx-pan-solid-tumor-liquid-biopsy-test

PGDx elio™ plasma focus Dx is the industry's first and only kitted, pan-solid tumor liquid biopsy test that enables tumor m...

 labcorps-stock-soars-after-q2-performance-analyst-highlights-strong-position-in-healthcare-sector

LabCorp reported Q2 2024 adjusted EPS of $3.94, surpassing expectations of $3.78. Sales increased by 6.2% to $3.22 billion, dri...

 labcorp-adjusts-fy24-outlook-cuts-adj-eps-guidance-from-1445-1535-to-1430-1490-vs-1482-estimate-raises-revenue-growth-outlook-from-48-64-to-64-75-vs-1283b-estimate

(Dollars in billions, except per share

 laboratory-corp-q2-2024-adj-eps-394-beats-378-estimate-sales-3220b-beat-3185b-estimate

Laboratory Corp (NYSE:LH) reported quarterly earnings of $3.94 per share which beat the analyst consensus estimate of $3.78 by ...

 labcorp-says-systems-are-currently-impacted-by-the-crowdstrike-computer-outage-affecting-companies-globally

- Reuters

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION